Leukemia & Lymphoma, Volume 64, Issue 14 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 64, Issue 14 (2023)

See all volumes and issues
Vol 65, 2024 Volume 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Review

Review Article
Functional drivers of resistance to anti-CD19 CAR-T cell therapy in diffuse large B cell lymphoma
Austin D. Newsam, Caroline A. Coughlin, Asaad Trabolsi & Jonathan H. Schatz
Pages: 2217-2224
Published online: 25 Dec 2023
AbstractforFunctional drivers of resistance to anti-CD19 CAR-T cell therapy in diffuse large B cell lymphoma | Full Text | References | PDF (1,005.9 KB) | EPUB
  • 1589 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Articles

Article
Phase 1b dose-finding study of rituximab, lenalidomide, and ibrutinib (R2I) in patients with relapsed/refractory mantle cell lymphoma
Andrew Ip, Alessandra Petrillo, Alexandra Della Pia, Geeny G. Lee, Sarvarinder Gill, Tony Varughese, Joshua Zenreich, Martin Gutierrez, Jiayu Zhang, Jaeil Ahn, Vishnu Bharani, Ava S. Nejad, Lauren Pascual, Tatyana A. Feldman, Lori A. Leslie & Andre H. Goy
Pages: 2225-2235
Published online: 25 Dec 2023
AbstractforPhase 1b dose-finding study of rituximab, lenalidomide, and ibrutinib (R2I) in patients with relapsed/refractory mantle cell lymphoma | Full Text | References | PDF (3.1 MB) | EPUB | Supplemental
  • 1462 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Embelin inhibits viability of cutaneous T cell lymphoma cell lines HuT78 and H9 by targeting inhibitors of apoptosis
Nabeel Abdulrahman, Rari Leo, Hasna Amal Boumenar, Fareed Ahmad, Jericha M. Mateo, Anh Jochebeth, Naila Khalid Al-Sowaidi, Gulab Sher, Abdul W. Ansari, Majid Alam, Shahab Uddin, Aamir Ahmad, Martin Steinhoff & Joerg Buddenkotte
Pages: 2236-2248
Published online: 14 Sep 2023
AbstractforEmbelin inhibits viability of cutaneous T cell lymphoma cell lines HuT78 and H9 by targeting inhibitors of apoptosis | Full Text | References | PDF (4.8 MB) | EPUB | Supplemental
  • 137 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Understanding treatment decisions for Hodgkin lymphoma: a qualitative study
Anita J. Kumar, Laurie K. Pearson, John B. Wong, Jonathan W. Friedberg, Susan K. Parsons & Amy M. LeClair
Pages: 2249-2257
Published online: 25 Dec 2023
AbstractforUnderstanding treatment decisions for Hodgkin lymphoma: a qualitative study | Full Text | References | PDF (760.6 KB) | EPUB | Supplemental
  • 87 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Influence of treatment intensity and medical comorbidities in older adults with peripheral T cell lymphoma
Max J. Gordon, Zhigang Duan, Hui Zhao, Loretta Nastoupil, Samuel Ng, Alexey V. Danilov, Swaminathan Iyer & Sharon H. Giordano
Pages: 2258-2268
Published online: 14 Sep 2023
AbstractforInfluence of treatment intensity and medical comorbidities in older adults with peripheral T cell lymphoma | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 167 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Comparative effectiveness between mosunetuzumab monotherapy clinical trial and real-world data in relapsed/refractory follicular lymphoma in third or subsequent lines of systemic therapy
Sarah F. McGough, Natasha Shamas, Jue Wang, Mahmoud Jaber, Binay Swarup, Marie-Hélène Blanchet Zumofen, Bertrand Lautié, Joana Parreira, Michael C. Wei & Ashwini Shewade
Pages: 2269-2278
Published online: 25 Dec 2023
AbstractforComparative effectiveness between mosunetuzumab monotherapy clinical trial and real-world data in relapsed/refractory follicular lymphoma in third or subsequent lines of systemic therapy | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 1768 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
Parastoo B. Dahi, Sheila Kenny, Jessica Flynn, Sean M. Devlin, Josel D. Ruiz, Stephanie A. Chinapen, Oscar B. Lahoud, Matthew J. Matasar, Craig H. Moskowitz, Miguel-Angel Perales, Gunjan Shah, Craig S. Sauter, Sergio A. Giralt, Alexander I. Geyer & Ann A. Jakubowski
Pages: 2279-2285
Published online: 10 Sep 2023
AbstractforUtility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma | Full Text | References | PDF (586.5 KB) | EPUB
  • 128 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia
Scott F. Huntington, Enrico de Nigris, Justin Puckett, Sachin Kamal-Bahl, Mohammed Farooqui, Katherine Ryland, Eric Sarpong, Siyang Leng, Xiaoqin Yang & Jalpa A. Doshi
Pages: 2286-2295
Published online: 25 Dec 2023
AbstractforIbrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia | Full Text | References | PDF (899.3 KB) | EPUB
  • 985 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Combined analysis of the impact of second-generation BTK inhibitors on patient outcomes
Robert A. Redd, Josie Ford, Matthew Lei, Jeremy S. Abramson & Jacob D. Soumerai
Pages: 2296-2305
Published online: 25 Dec 2023
AbstractforCombined analysis of the impact of second-generation BTK inhibitors on patient outcomes | Full Text | References | PDF (3.1 MB) | EPUB | Supplemental
  • 252 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL
Emily Tomasulo, Shira Paul, Rui Mu, Xin Tian, Jonathan Chen, Christopher Pleyer, Adrian Wiestner & Clare Sun
Pages: 2306-2315
Published online: 25 Dec 2023
AbstractforInterruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL | Full Text | References | PDF (2.8 MB) | EPUB | Supplemental
  • 217 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia
Scott F. Huntington, Beenish S. Manzoor, Justin T. Puckett, Sachin Kamal-Bahl, Hasan Alhasani, Arliene Ravelo, Dureshahwar Jawaid & Jalpa A. Doshi
Pages: 2316-2323
Published online: 25 Dec 2023
AbstractforReal-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia | Full Text | References | PDF (1.1 MB) | EPUB
  • 1165 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Validation of imatinib therapy failure score (IMTF) in chronic phase chronic myeloid leukemia in real life practice
Claudia Ielo, Emilia Scalzulli, Ida Carmosino, Sara Pepe, Maria Laura Bisegna, Maurizio Martelli & Massimo Breccia
Pages: 2324-2326
Published online: 10 Sep 2023
AbstractforValidation of imatinib therapy failure score (IMTF) in chronic phase chronic myeloid leukemia in real life practice | Full Text | References | PDF (404.3 KB) | EPUB
  • 99 Views
  • 0 CrossRef citations
  • 0Altmetric

Letters to the Editor

Primary central nervous system lymphoma in children - a rare but serious disease with good prognosis from a single center in China
Yanlong Duan, Huixia Gao, Chunju Zhou, Ling Jin, Jing Yang, Shuang Huang, Ningning Zhang, Meng Zhang, Xueliang Yang, Yonghong Zhang & Tianyou Wang
Pages: 2327-2332
Published online: 25 Dec 2023
First Page PreviewforPrimary central nervous system lymphoma in children - a rare but serious disease with good prognosis from a single center in China | Full Text | References | PDF (1,017.6 KB) | EPUB
  • 63 Views
  • 0 CrossRef citations
  • 0Altmetric
Preclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies
Audrey L. Smith, Dhananjaya Pal, Rolando Martinez-Rico, Alexandria P. Eiken, Donald L. Durden, Tatiana G. Kutateladze & Dalia El-Gamal
Pages: 2333-2337
Published online: 14 Sep 2023
First Page PreviewforPreclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 174 Views
  • 0 CrossRef citations
  • 0Altmetric
Myeloid/lymphoid neoplasm with a novel cryptic RBPMS::FGFR1 rearrangement presenting as de novo acute leukemias
Tianyu Yang, Nayyara Mahmood, Bradley Goldberg, Johnny Cevallos, Peihong Hsu, Jonathan Kolitz, Ninette Cohen & Xinmin Zhang
Pages: 2338-2342
Published online: 25 Dec 2023
First Page PreviewforMyeloid/lymphoid neoplasm with a novel cryptic RBPMS::FGFR1 rearrangement presenting as de novo acute leukemias | Full Text | References | PDF (4.2 MB) | EPUB | Supplemental
  • 151 Views
  • 0 CrossRef citations
  • 0Altmetric
Severe chronic primary neutropenia: findings from a patient who underwent exstensive evaluation including adenosine deaminase 2 gene variant assessment
Katia Paciaroni, Eugenio Sangiorgi, Federica Pulvirenti, Nicoletta Villiva, Cristina Andrizzi, Selenia Campagna, Attilio Tordi, Francesca Celesti, Raffaele Manna, Fiorella Gurrieri, Stefano Licci & Tommaso Caravita di Toritto
Pages: 2343-2346
Published online: 12 Sep 2023
First Page PreviewforSevere chronic primary neutropenia: findings from a patient who underwent exstensive evaluation including adenosine deaminase 2 gene variant assessment | Full Text | References | PDF (844.5 KB) | EPUB
  • 55 Views
  • 0 CrossRef citations
  • 0Altmetric
Allogeneic hematopoietic stem cell transplantation in adults with dendritic/histiocytic neoplasms
Charles Gaulin, Fiona Craig, Shannon Fortin Ensign, Ryan Robetorye, Sarah Gibson, Katalin Kelemen, Nandita Khera, Jose Leis, Mazie Tsang, Allison Rosenthal, Javier Munoz, Jeanne Palmer & Talal Hilal
Pages: 2347-2350
Published online: 07 Sep 2023
First Page PreviewforAllogeneic hematopoietic stem cell transplantation in adults with dendritic/histiocytic neoplasms | Full Text | References | PDF (909.6 KB) | EPUB
  • 108 Views
  • 0 CrossRef citations
  • 0Altmetric
Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab
Robert Stuver, Santosha A. Vardhana, Akshay Bedmutha, Karmela Kim Chan, Rosna Mirtcheva-Trocheva, Anton Nosov, Heiko Schöder & Alison Moskowitz
Pages: 2351-2353
Published online: 25 Dec 2023
First Page PreviewforDisease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab | Full Text | References | PDF (1.1 MB) | EPUB
  • 158 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles